Tag: Glenmark Pharmaceuticals

Stocks that will see action today: October 14, 2024

Posted on October 14, 2024 by filesadmin

]Wipro on Sunday said its board of directors will consider the issue of bonus shares at a meeting scheduled to

Glenmark to pay $25 million as part of settlement with US authorities

Posted on September 5, 2024 by filesadmin

Shares of Glenmark were trading 1.22 per cent up at Rs 1,708.25 apiece on the BSE. 2 min read Last

Glenn Saldanha announced resignation as chairman of Glenmark Life Sciences | Company News – Business Standard

Posted on March 6, 2024 by filesadmin

Glenmark Life Sciences Ltd on Wednesday said its Chairman Glenn Saldanha and non-executive director VS Mani have resigned following

Utkarsh Small Finance Bank proposes reverse merger with holding entity | Company News – Business Standard

Posted on February 14, 2024 by filesadmin

Govind Singh, MD & CEO, Utkarsh Small Finance Bank Utkarsh Small Finance Bank, on Wednesday, informed the exchanges that

Glenmark Pharmaceuticals launches antidiabetic drug ‘Lirafit’ in India

Posted on January 3, 2024 by filesadmin

Lirafit will be available only under prescription Glenmark Pharmaceuticals on Wednesday said it has launched a biosimilar of the

Ichnos Sciences, Astria Therapeutics sign licensing deal for OX40 portfolio

Posted on October 13, 2023 by filesadmin

Glenmark Pharmaceuticals’ wholly owned subsidiary Ichnos Sciences, a clinical-stage oncology biotech, and Astria Therapeutics, a biopharmaceutical company developing therapies

Glenmark eyes double-digit revenue growth; to focus on debt reduction

Posted on September 10, 2023 by filesadmin

Glenmark Pharmaceuticals aims to grow its revenues by 10-11 per cent with a focus on free cash generation to

Glenmark Pharma, Teva settle drug pricing cases with US Dept of Justice

Posted on August 23, 2023 by filesadmin

Mumbai-based drugmaker Glenmark Pharmaceuticals said that it has entered into a pact with the US Department of Justice, Antitrust

Nirma, Sekhmet Pharmaventures vie for $731 mn Glenmark Life stake: Reports

Posted on July 14, 2023 by filesadmin

Written by Manuel Baigory, Vincey Chan, and Baiju Kalish Indian conglomerate Nirma Ltd. and PAG-backed Sekhmet Pharmaventures are among

To Acquire Glenmark’s API business: Sekhmet Pharmaventures, Nirma in Race

Posted on June 12, 2023 by filesadmin

Sekhmet Pharmaventures has joined the race to acquire BSE-listed Glenmark Life Sciences (GLS) as promoter Glenn Saldanha looks to reduce

Recent Posts